MALT LYMPHOMA

Clinical trials for MALT LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new MALT LYMPHOMA trials appear

Sign up with your email to follow new studies for MALT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New Two-Pronged attack on rare lymphoma shows promise

Disease control Ongoing

This study tested a two-part treatment for MALT lymphoma, a type of slow-growing cancer. First, patients received a combination of two drugs (chlorambucil and rituximab) to try to shrink the cancer. Then, patients who responded or had stable disease received long-term, lower-dose…

Matched conditions: MALT LYMPHOMA

Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

MALT LYMPHOMA

Get alerted when new MALT LYMPHOMA trials appear

New Two-Pronged attack on rare lymphoma shows promise